Purchase Order 36C26122P1109
- Not listed
- This is a $125,722.90 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Denver Solutions, LLC, a for-profit limited liability company. The contract is for the delivery of the pharmaceutical product ropivacaine hydrochloride injection to support VA medical facilities. Denver Solutions is an FDA-registered 503B outsourcing facility that specializes in compounded sterile pharmaceutical products,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ropivacaine 0.2% (400 mg/200 mL) with a ceiling value of $3,053.70 under a firm fixed price arrangement. The award was made on May 19, 2025, with an ultimate completion date of May 20, 2025, and performed at the vendor's Conshohocken, Pennsylvania facility. This non-set-aside award represents a single delivery order issued against AmerisourceBergen's larger pharmaceutical supply contract vehicle with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5% ropivacaine 150 mg/30 ml (30 ml) at a ceiling value of $2,104.56. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ropivacaine 0.2% 400 mg/200 ml medical products. The order has a firm fixed price of $1,749.64 and a completion date of January 28, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,558.35, is for the supply of 400 mg/200 mL vials of Ropivacaine 0.2% anesthetic. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,775.55, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml (200 ml) medical supplies. The contract has an ultimate completion date of May 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.08 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 mL in 200 mL units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 2, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- This is a $1,607.68 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 400 mg/200 mL of the anesthetic drug ropivacaine 0.2%. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This contract award is for the delivery of 400 mg/200 mL vials of ropivacaine 0.2% solution, a local anesthetic medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,873.51, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 27, 2023 and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,877.64, is for the delivery of 4562519583 ROPIVACAINE 0.2% 400 MG/200 ML 200ML medical supplies. The contract has a firm fixed price pricing type and an ultimate completion date of October 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Denver Solutions, LLC, an FDA-registered 503B outsourcing provider. The $97,431.43 contract is for the delivery of sterile compound products, including injectables like ropivacaine, ketamine, phenylephrine, and ephedrine, as well as sterile compound kits and LEITERS (liquid-filled implantable drug delivery systems). The contract is not set-aside and runs through September 30, 2022. In addition to this purchase order, Denver Solutions holds two major Indefinite Delivery Contracts (IDCs) with the VA - a $173,000 IDC through September 2025 and a $786,527 IDC from May 2022 through September 2023 - to provide 503B compounded supplies and LEITERS to VA medical facilities, primarily supporting the Minneapolis area.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($6k) | 6/18/24 | |
| P00001 | Supplemental Agreement for work within scope | $7.7k | 3/9/23 | |
| Not listed | Not listed | $95.5k | 5/27/22 |